American Gene Technologies International
Business Services · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9713 Key West Ave Fl 5, Rockville, Maryl...Phone Number
(301) 337-2100Website
www.americangene.comRevenue
$25.4 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About American Gene Technologies International
American Gene Technologies is a biotechnology company specializing in gene and cell therapies, utilizing a proprietary lentiviral platform for various applications. The company is focused on developing clinical cures for complex diseases, including HIV and certain cancers, and has received FDA Orphan Drug Approval for its treatment of Phenylketonuria (PKU). With a commitment to advancing medical breakthroughs, AGT is actively conducting clinical trials and has secured multiple patents for its innovative therapies. Their target clients include patients suffering from serious diseases, as well as the broader healthcare community seeking effective treatment solutions.Explore more
American Gene Technologies International Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is American Gene Technologies International your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if American Gene Technologies International had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at American Gene Technologies International
Check out if American Gene Technologies International is spiking on competitors!
Funding: Get notified immidiatlly once American Gene Technologies International has new funding data
Earning: See what the market has to say on American Gene Technologies International recently announced quarterly report
Check if American Gene Technologies International has recently received funding, and reach out quickly before it becomes old news!
American Gene Technologies International, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when American Gene Technologies International launches new products
Recommended Actions
Find VP level buyers at American Gene Technologies International
Find 3 more new buyers
Compare Similar Companies to American Gene Technologies International
Compare insights from companies similar to American Gene Technologies International, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5.2M
11-50
Private
<$5M
2013
TN
Tushar NuwalBusiness Corporate Development, Alliance Management & Commercial Strategy Head
Company Profile Activity
Activity Insights
American Gene Technologies International is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
American Gene Technologies International is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about American Gene Technologies International.
American Gene Technologies International financials insights
Gather financial insights about American Gene Technologies International, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$1.2M
2020
Debt
$350K
American Gene Technologies International Tech Stack
A closer look at the technologies used by American Gene Technologies International
Most Recent Scoops
Project
Product Development, Business Development
New Hire
Executive Move
Award
Award
Funding
American Gene Technologies International News & Media
Addimmune, a Clinical Stage Hiv-Focused Gene Therapy Company, to go Public Through Business Combination With 10x Capital Venture Acquisition Corp. III
NEW YORK CITY, NEW YORK and ROCKVILLE, MARYLAND, Aug. 09, 2023 (GLOBE NEWSWIRE) -- NEW YORK CITY, NEW YORK and ROCKVILLE, MARYLAND, Aug. 9, 2023 (GLOBE NEWSWIRE) – American Gene Technologies International Inc. (“AGT”) and 10X Capital Venture Acquisition Corp. III (“10X III”) (NYSE: VCXB), a special purpose acquisition company, today announced that they have entered into a merger agreement for a business combination that would result in the combined company being a publicly listedAmerican Gene Technologies Spinoff Sets Sights on Advancing Cell Therapy for HIV
Addimmune will separate from AGT within a year with the goal of quickly raising funds and moving AGT103-T into Phase II trials.American Gene Technologies Launches New Spinoff Company “Addimmune” to Focus Exclusively on Development of HIV Cure
Addimmune will build upon the success of American Gene Technologies Phase 1 HIV clinical trial, accelerating the clinical development with... Read More The post American Gene Technologies Launches New Spinoff Company “Addimmune” to Focus Exclusively on Development of HIV Cure appeared first on citybiz.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding American Gene Technologies International
Sign Up For FreeTo access detailed company insights
American Gene Technologies is a biotechnology company specializing in gene and cell therapies, utilizing a proprietary lentiviral platform for various applications. The company is focused on developing clinical cures for complex diseases, including HIV and certain cancers, and has received FDA Orphan Drug Approval for its treatment of Phenylketonur... Read More
